Next, we evaluated the excretion, metabolism, and tissue distribution of BPC157 in rats after a single IM injection of 100 g/300 Ci/kg [ 3 H]BPC157
The FDAs own language makes it clear: Compounded drugs containing BPC-157 may pose risk for immunogenicity and may have complexities with regard to peptide-related impurities and API characterization. In plain terms, the FDA is worried about shady, unregulated research-use-only peptides sold online not about what happens when BPC-157 is responsibly compounded, tested for purity, and dispensed under medical supervision
Reinventing a familiar molecule Veradermics, meanwhile, is taking a more formulation-driven approach
To reduce the chance of a reaction, choose a product with minimal additives and avoid using it alongside harsh actives unless advised by a professional
HUBERMAN: Now that raises the question, what turns on GNRH